Your institution may have access to this item. Find your institution then sign in to continue.
Title
Science briefs.
Abstract
This section offers news briefs concerning the pharmaceutical industry. Researchers from the University of Texas Southwestern have identified five peptoids that are capable of binding VEGFR2, a target for an antibody cancer treatment. An orphan drug status has been granted by the European Commission to Mapreg for its lead compound MAP4343. Evotec has signed a discovery contract with Japan's Ono Pharmaceutical targeting an unidentified protease selected by Ono.